231 related articles for article (PubMed ID: 6317576)
1. Characterization of malignant and non-neoplastic cell phenotypes in highly malignant non-Hodgkin lymphomas.
Porwit-Ksiazek A; Christensson B; Lindemalm C; Mellstedt H; Tribukait B; Biberfeld G; Biberfeld P
Int J Cancer; 1983 Dec; 32(6):667-74. PubMed ID: 6317576
[TBL] [Abstract][Full Text] [Related]
2. The cellular content of non Hodgkin lymphomas: a comprehensive analysis using monoclonal antibodies and other surface marker techniques.
Habeshaw JA; Bailey D; Stansfeld AG; Greaves MF
Br J Cancer; 1983 Mar; 47(3):327-51. PubMed ID: 6338896
[TBL] [Abstract][Full Text] [Related]
3. Immunopathology of non-Hodgkin lymphomas.
Huber H; Gattringer C; Knapp W; Stein H
Klin Wochenschr; 1984 Nov; 62(21):1001-10. PubMed ID: 6392723
[TBL] [Abstract][Full Text] [Related]
4. [Classification of non-Hodgkin's lymphomas on the basis of Morphological and immunological features shared by normal and neoplastic lymphatic cells (author's transl)].
Stein H
Immun Infekt; 1976 Apr; 4(2):52-69. PubMed ID: 1085745
[TBL] [Abstract][Full Text] [Related]
5. Surface phenotyping, histology and the nature of non-Hodgkin lymphoma in 157 patients.
Habeshaw JA; Catley PF; Stansfeld AG; Brearley RL
Br J Cancer; 1979 Jul; 40(1):11-34. PubMed ID: 314300
[TBL] [Abstract][Full Text] [Related]
6. Lymphoblastic lymphoma with the phenotype of common acute lymphoblastic leukemia.
Borowitz MJ; Croker BP; Metzgar RS
Am J Clin Pathol; 1983 Mar; 79(3):387-91. PubMed ID: 6338702
[TBL] [Abstract][Full Text] [Related]
7. Immune marker expression in 53 lymphomas of high-grade malignancy.
Pallesen G; Madsen M; Schifter S
Histopathology; 1983 Nov; 7(6):841-57. PubMed ID: 6689315
[TBL] [Abstract][Full Text] [Related]
8. Imbalance of helper and suppressor T lymphocytes in malignant non-Hodgkin lymphomas: an in situ morphometric analysis.
Gattringer C; Huber H; Radaszkiewicz T; Pfaller W; Braunsteiner H
Int J Cancer; 1984 Jun; 33(6):751-7. PubMed ID: 6234239
[TBL] [Abstract][Full Text] [Related]
9. Clinical and prognostic relevance of the Kiel classification of non-Hodgkin lymphomas results of a prospective multicenter study by the Kiel Lymphoma Study Group.
Brittinger G; Bartels H; Common H; Dühmke E; Fülle HH; Gunzer U; Gyenes T; Heinz R; König E; Meusers P
Hematol Oncol; 1984; 2(3):269-306. PubMed ID: 6384008
[TBL] [Abstract][Full Text] [Related]
10. Reactivity of Leu 1 and T101 monoclonal antibodies with B cell lymphomas (correlations with other immunological markers).
Al Saati T; Laurent G; Caveriviere P; Rigal F; Delsol G
Clin Exp Immunol; 1984 Dec; 58(3):631-8. PubMed ID: 6239721
[TBL] [Abstract][Full Text] [Related]
11. [Studies of immunologic markers in malignant lymphomas: diagnostic and prognostic relevance].
Huber H; Thaler J; Greil R; Gattringer C; Radaszkiewicz T
Onkologie; 1986 Apr; 9(2):108-13. PubMed ID: 3520418
[TBL] [Abstract][Full Text] [Related]
12. Immunoelectron microscopic localization of immunoglobulin in B-cell lymphomas.
Mimura R; Hansmann ML; Lennert K
Virchows Arch B Cell Pathol Incl Mol Pathol; 1986; 52(3):207-20. PubMed ID: 2879378
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic and functional analyses of tumour-infiltrating Leu 7 + natural killer-like cells in non-Hodgkin lymphomas.
Banerjee D
Cancer Detect Prev Suppl; 1987; 1():103-9. PubMed ID: 3500777
[TBL] [Abstract][Full Text] [Related]
14. Immunologic markers in non-Hodgkin's lymphoma.
Freedman AS; Nadler LM
Hematol Oncol Clin North Am; 1991 Oct; 5(5):871-89. PubMed ID: 1938759
[TBL] [Abstract][Full Text] [Related]
15. Analysis of large-cell lymphomas using monoclonal and heterologous antibodies.
van der Valk P; van den Besselaar-Dingjan G; Daha MR; Meijer CJ
J Clin Pathol; 1983 Jan; 36(1):44-50. PubMed ID: 6337190
[TBL] [Abstract][Full Text] [Related]
16. Nature of non-B, non-T lymphomas: an immunohistological study on frozen tissues using monoclonal antibodies.
Pallesen G; Beverley PC; Lane EB; Madsen M; Mason DY; Stein H
J Clin Pathol; 1984 Aug; 37(8):911-8. PubMed ID: 6381546
[TBL] [Abstract][Full Text] [Related]
17. Antigenically defined subgroups of lymphoblastic lymphoma. Relationship to clinical presentation and biologic behavior.
Sheibani K; Nathwani BN; Winberg CD; Burke JS; Swartz WG; Blayney D; van de Velde S; Hill LR; Rappaport H
Cancer; 1987 Jul; 60(2):183-90. PubMed ID: 2954631
[TBL] [Abstract][Full Text] [Related]
18. Correlation between histology and immunophenotype in a series of 322 cases of non-Hodgkin's lymphoma.
Smith JL; Jones DB; Bell AJ; Wright DH
Hematol Oncol; 1989; 7(1):37-48. PubMed ID: 2642457
[TBL] [Abstract][Full Text] [Related]
19. Growth fraction of tumour cells and infiltration density with natural killer-like (HNK1+) cells in non-Hodgkin lymphomas.
Greil R; Gattringer C; Knapp W; Huber H
Br J Haematol; 1986 Feb; 62(2):293-300. PubMed ID: 3004554
[TBL] [Abstract][Full Text] [Related]
20. A clinico-pathological and immunological study of unfavourable non-Hodgkin lymphomas. Comparison of the Rappaport and Kiel classifications.
Lindemalm C; Christensson B; Johansson B; Mellstedt H; Ost A; Biberfeld P
Acta Pathol Microbiol Immunol Scand A; 1983 Nov; 91(6):435-43. PubMed ID: 6364692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
